• Featured Product
  • KD/KO Validated

TRAF4 Monoklonaler Antikörper

TRAF4 Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

Hausschwein, human

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

2C9A11

Kat-Nr. : 66755-1-PBS

Synonyme

2C9A11, CART1, Cysteine-rich domain associated with RING and Traf domains protein 1, EC:2.3.2.27, MLN 62



Geprüfte Anwendungen

Produktinformation

66755-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA TRAF4 und zeigt Reaktivität mit Hausschwein, human

Getestete Reaktivität Hausschwein, human
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen TRAF4 fusion protein Ag27221
Vollständiger Name TNF receptor-associated factor 4
Berechnetes Molekulargewicht 54 kDa
Beobachtetes Molekulargewicht 50-54 kDa
GenBank-ZugangsnummerBC001769
Gene symbol TRAF4
Gene ID (NCBI) 9618
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

The tumor necrosis factor receptor-associated factor (TRAF) family, consisting of seven members (TRAF1-7), is a group of signaling adaptors which participate in various signaling pathways through binding of the tumor necrosis factor receptor superfamily. As one of the important member of TRAF family proteins, TRAF4 was initially isolated from breast carcinomas and identified as the first member of the TRAF family to be up-regulated in human carcinomas. TRAF4 is required during embryogenesis in key biological processes including the formation of the trachea, the development of the axial skeleton, and the closure of the neural tube. TRAF4 deficiency leads to severe developmental alterations.